French medtech entrepreneurialism needs infrastructural back-up
This article was originally published in Clinica
France does not lack innovative capacity in medical devices, but the infrastructures to support SMEs and start-ups need to be improved. That is the view of Odile Corbin, head of French medtech industry association Snitem. On a recent Snitem press trip to local innovators SuperSonic Imagine and Ekkyo, the consensus was that medtech companies need more help in clearing the increasingly high regulatory hurdles and also in gaining access to funding in France’s new healthcare landscape. IBI Informa principal analyst Ashley Yeo reports
You may also be interested in...
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.